Speaker illustration

Doctor Rohan Wijesurendra

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Dr Rohan Wijesurendra MBBChir MA (Cantab) DPhil (Oxon) MRCP is a Clinical Lecturer in Cardiovascular Medicine and Cardiology Registrar in Oxford, United Kingdom. He completed medical training at Cambridge University with several prizes and scholarships, before moving to Oxford for higher training and specialisation in Cardiology in 2011. He completed his DPhil (PhD) in Cardiovascular Medicine in Oxford in 2018, and now combines post-doctoral research with an active clinical practice in Cardiology and Electrophysiology. His current research interests include clinical trials, cardiac magnetic resonance imaging and spectroscopy, and AF and arrhythmia.

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation

Event: EHRA 2023

Topic: Diagnostic Methods

Session: Atrial Fibrillation - Round 1 - Drugs, Prevention

Thumbnail

Determinants of post-operative atrial fibrillation in 1613 patients undergoing coronary artery bypass grafting in the Statin Therapy In Cardiac Surgery (STICS) trial

Event: ESC Congress 2022

Topic: Clinical

Session: Treatment of atrial fibrillation in patient with coronary artery disease

Thumbnail

Perioperative rosuvastatin therapy increases creatine kinase and the risk of acute kidney injury in patients undergoing cardiac surgery

Event: ESC Congress 2022

Topic: Lipid-Lowering Agents

Session: Statin therapy: clinical role and current challenges

Thumbnail

Atrial cardiomyopathy: valuable concept or just another buzzword?

Event: ESC Congress 2019

Topic: Basic Science

Session: Atrial cardiomyopathies

Thumbnail

Influence of body mass change and occurance of atrial fibrillation.

Event: EuroPrevent 2019

Topic: Atrial Fibrillation (AF)

Session: Masterclass: stroke prevention I

Thumbnail

Myocarditis in a young man initially manifesting as aborted sudden cardiac death and subsequently complicated by recurrent ventricular tachycardia.

Event: ESC Congress 2018

Topic: European Society of Cardiology, Other

Session: Best clinical cases - Awards session

Thumbnail

Novel strategies to treat atrial fibrillation: Much ado about nothing?

Event: ESC Congress 2018

Topic: Cardiac Diseases

Session: Atrial fibrillation - Not all quiet on the molecular front

Thumbnail

Non-contrast methods to evaluate the myocardium in tachyarrhythmias.

Event: CMR 2018 (the 5th joint EuroCMR/SCMR meeting)

Topic: Cardiac Magnetic Resonance (CMR)

Session: Technologist Track: Electrophysiology

Thumbnail

The interplay between left ventricular function and diffuse fibrosis in patients with atrial fibrillation undergoing ablation: insights from a prospective longitudinal cardiac magnetic resonance study

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Advances in ablation for atrial fibrillation

Thumbnail

Atrial fibrillation is associated with impaired left ventricular energetics that persist despite successful catheter ablation

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Young Investigators Awards Session Clinical Science

Thumbnail

ESC 365 is supported by